Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Related Citations for PubMed (Select 22569095)

1.

Selectivity of the ubiquitin-binding modules.

Rahighi S, Dikic I.

FEBS Lett. 2012 Aug 14;586(17):2705-10. doi: 10.1016/j.febslet.2012.04.053. Epub 2012 May 5. Review.

2.

Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling.

Varadan R, Assfalg M, Haririnia A, Raasi S, Pickart C, Fushman D.

J Biol Chem. 2004 Feb 20;279(8):7055-63. Epub 2003 Nov 25.

3.

Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do not.

Verhelst K, Verstrepen L, Carpentier I, Beyaert R.

Biochem Pharmacol. 2011 Nov 1;82(9):1057-65. doi: 10.1016/j.bcp.2011.07.066. Epub 2011 Jul 20.

PMID:
21787758
4.

Reading the ubiquitin postal code.

Trempe JF.

Curr Opin Struct Biol. 2011 Dec;21(6):792-801. doi: 10.1016/j.sbi.2011.09.009. Epub 2011 Oct 27. Review.

PMID:
22036065
5.
6.

Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.

Chiaravalli J, Fontan E, Fsihi H, Coic YM, Baleux F, Véron M, Agou F.

Biochem Pharmacol. 2011 Nov 1;82(9):1163-74. doi: 10.1016/j.bcp.2011.07.083. Epub 2011 Jul 23.

PMID:
21803029
7.

Ubiquitylation within signaling pathways in- and outside of inflammation.

Hochrainer K, Lipp J.

Thromb Haemost. 2007 Mar;97(3):370-7. Review.

PMID:
17334503
8.

Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch.

Long J, Gallagher TR, Cavey JR, Sheppard PW, Ralston SH, Layfield R, Searle MS.

J Biol Chem. 2008 Feb 29;283(9):5427-40. Epub 2007 Dec 14.

9.

Selective binding of linear ubiquitin chains to NEMO in NF-kappaB activation.

Ikeda F, Rahighi S, Wakatsuki S, Dikic I.

Adv Exp Med Biol. 2011;691:107-14. doi: 10.1007/978-1-4419-6612-4_11. No abstract available.

PMID:
21153314
10.

Diverse ubiquitin signaling in NF-κB activation.

Iwai K.

Trends Cell Biol. 2012 Jul;22(7):355-64. doi: 10.1016/j.tcb.2012.04.001. Epub 2012 Apr 28. Review.

PMID:
22543051
11.

Using NMR spectroscopy to monitor ubiquitin chain conformation and interactions with ubiquitin-binding domains.

Ranjani Varadan, Assfalg M, Fushman D.

Methods Enzymol. 2005;399:177-92.

PMID:
16338356
12.

Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.

Lin R, Yang L, Nakhaei P, Sun Q, Sharif-Askari E, Julkunen I, Hiscott J.

J Biol Chem. 2006 Jan 27;281(4):2095-103. Epub 2005 Nov 23.

13.

Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin.

Yoshikawa A, Sato Y, Yamashita M, Mimura H, Yamagata A, Fukai S.

FEBS Lett. 2009 Oct 20;583(20):3317-22. doi: 10.1016/j.febslet.2009.09.028. Epub 2009 Sep 18.

14.

The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination.

Wooten MW, Geetha T, Seibenhener ML, Babu JR, Diaz-Meco MT, Moscat J.

J Biol Chem. 2005 Oct 21;280(42):35625-9. Epub 2005 Aug 3.

15.

Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).

Blankenship JW, Varfolomeev E, Goncharov T, Fedorova AV, Kirkpatrick DS, Izrael-Tomasevic A, Phu L, Arnott D, Aghajan M, Zobel K, Bazan JF, Fairbrother WJ, Deshayes K, Vucic D.

Biochem J. 2009 Jan 1;417(1):149-60. doi: 10.1042/BJ20081885.

16.

Structure of a compact conformation of linear diubiquitin.

Rohaim A, Kawasaki M, Kato R, Dikic I, Wakatsuki S.

Acta Crystallogr D Biol Crystallogr. 2012 Feb;68(Pt 2):102-8. doi: 10.1107/S0907444911051195. Epub 2012 Jan 13.

PMID:
22281738
17.

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM.

Nature. 2004 Aug 5;430(7000):694-9. Epub 2004 Jul 18.

PMID:
15258597
18.

Constructing and decoding unconventional ubiquitin chains.

Behrends C, Harper JW.

Nat Struct Mol Biol. 2011 May;18(5):520-8. doi: 10.1038/nsmb.2066. Review.

PMID:
21540891
19.

Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway.

Lee MJ, Pal K, Tasaki T, Roy S, Jiang Y, An JY, Banerjee R, Kwon YT.

Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):100-5. Epub 2007 Dec 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk